In accord with our in vitro findings where RhoA knockdown did not influence breast cancer cell proliferation, at 30 days post-implantation we did not observe any statistically significant changes in weights or expression levels of proliferation antigen ki67 in RhoA knockdown primary tumors when compared with knockdown control (Supplementary Fig. 2). This evidence concerns the gene MKI67 and breast cancer.